A call for global oversight of unproven stem cell therapies
‘Breakthrough’ COVID infections may be common in vaccinated transplant patients
8 June 2021Study finds ‘significant reduction’ in GP trainee burnout following mindfulness program
8 June 2021A call for global oversight of unproven stem cell therapies
The promotion and marketing of unproven stem cell therapies is a global problem that needs a global solution, say experts in a perspective published June 8 in the journal Stem Cell Reports. The authors of the paper call for the World Health Organization (WHO) to establish an advisory committee on regenerative medicine to tackle this issue and provide guidance for countries around the world.
